SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Soligenix Announces $300,000 National Cancer Institute SBIR Grant Award Supporting a Phase 2 Trial of orBec® as a Treatment for Chronic GI GVHD